Cargando…
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
BACKGROUND AND PURPOSE: Locally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a cohort enrolled across two institutions investigating MRI-guided tumor-targeted salvage high dose rate brachytherapy (H...
Autores principales: | Ménard, Cynthia, Navarro-Domenech, Inmaculada, Liu, Zhihu (Amy), Joseph, Lisa, Barkati, Maroie, Berlin, Alejandro, Delouya, Guila, Taussky, Daniel, Beauchemin, Marie-Claude, Nicolas, Benedicte, Kadoury, Samuel, Rink, Alexandra, Raman, Srinivas, Sundaramurthy, Aravindhan, Weersink, Robert, Beliveau-Nadeau, Dominic, Helou, Joelle, Chung, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459480/ https://www.ncbi.nlm.nih.gov/pubmed/36091157 http://dx.doi.org/10.3389/fonc.2022.971344 |
Ejemplares similares
-
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022) -
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results
por: Lauche, Olivier, et al.
Publicado: (2016) -
A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019) -
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022) -
Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)